Literature DB >> 10955853

Permeation studies in vitro and in vivo of potential radiopharmaceuticals with affinity to neuro receptors.

M Friebe1, K Suda, H Spies, R Syhre, R Berger, B Johannsen, E Chiotellis, S D Krämer, H Wunderli-Allenspach.   

Abstract

PURPOSE: To check the influence of structural characteristics on their permeation through the blood-brain barrier (BBB), a set of radioactive [99mTc]chelates bearing amine groups was synthesized and tested in vitro as well as in vivo.
METHODS: Compounds with different log P and pKa values were obtained by complex forming reactions of [99mTc]pertechnetate with varying substituents. Transport was studied in rats and mice, as well as in an ECV304 cell culture model.
RESULTS: In vitro higher permeation was found for compounds with electron attracting substituents in beta-position to the amine group (pKa values 7.4 to 8.3) than for those with more basic amine groups (pKa values > 8.9) even for similar log DH 7.4. In vivo brain uptake between 0.8 and 4.8% of the injected dose (ID) per organ was found for the former, whereas <0.4% ID were present for the latter.
CONCLUSIONS: Three structurally diverse classes of [99mTc]chelates showed distinct patterns with regard to brain uptake in vivo and BBB permeability in vitro which could not be predicted by their lipophilicity alone. The close correlation between the data from rats and mice and those obtained with cell cultures render the ECV304 cells an attractive model for the screening of new compounds.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955853     DOI: 10.1023/a:1007598703357

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  Imaging of dopamine transporters in humans with technetium-99m TRODAT-1.

Authors:  H F Kung; H J Kim; M P Kung; S K Meegalla; K Plössl; H K Lee
Journal:  Eur J Nucl Med       Date:  1996-11

2.  MDCK cell cultures as an epithelial in vitro model: cytoskeleton and tight junctions as indicators for the definition of age-related stages by confocal microscopy.

Authors:  B Rothen-Rutishauser; S D Krämer; A Braun; M Günthert; H Wunderli-Allenspach
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 3.  The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system.

Authors:  D J Begley
Journal:  J Pharm Pharmacol       Date:  1996-02       Impact factor: 3.765

4.  Structural modification of receptor-binding technetium-99m complexes in order to improve brain uptake.

Authors:  B Johannsen; R Berger; P Brust; H J Pietzsch; M Scheunemann; S Seifert; H Spies; R Syhre
Journal:  Eur J Nucl Med       Date:  1997-03

5.  Molecular factors influencing drug transfer across the blood-brain barrier.

Authors:  J A Gratton; M H Abraham; M W Bradbury; H S Chadha
Journal:  J Pharm Pharmacol       Date:  1997-12       Impact factor: 3.765

6.  Lipid solubility and drug penetration of the blood brain barrier.

Authors:  W H Oldendorf
Journal:  Proc Soc Exp Biol Med       Date:  1974-12

7.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists.

Authors:  R C Young; R C Mitchell; T H Brown; C R Ganellin; R Griffiths; M Jones; K K Rana; D Saunders; I R Smith; N E Sore
Journal:  J Med Chem       Date:  1988-03       Impact factor: 7.446

8.  Synthesis, characterization and biodistribution of new 99mTc Oxo and nitrido complexes of unsaturated tetradentate (N2S2)ligands.

Authors:  Y Coulais; G Cros; M H Darbieu; P Gantet; J A Tafani; D Vende; R Pasqualini; R Guiraud
Journal:  Nucl Med Biol       Date:  1993-04       Impact factor: 2.408

9.  Metabolism of 99mTc-L,L-ethyl cysteinate dimer in healthy volunteers.

Authors:  R C Walovitch; M Franceschi; M Picard; E H Cheesman; K M Hall; J Makuch; M W Watson; R E Zimmerman; A D Watson; M V Ganey
Journal:  Neuropharmacology       Date:  1991-03       Impact factor: 5.250

10.  Stability versus reactivity of "3+1" mixed-ligand technetium-99m complexes in vitro and in vivo.

Authors:  R Syhre; S Seifert; H Spies; A Gupta; B Johannsen
Journal:  Eur J Nucl Med       Date:  1998-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.